Effects of Group Cognitive-Behavioral Therapy in Young Patients in the Early Stage of Psychosis

다국어 초록 (Multilingual Abstract)

Objective: To develop a model of group cognitive-behavioral therapy (CBT) for Korean patients with early psychosis.
Methods: The group CBT utilized in the present study consisted of metacognitive training, cognitive restructuring, and lifestyle managements. The Subjective Well-being Under Neuroleptics (SWN-K), Ambiguous Intentions Hostility Questionnaire (AIHQ), Drug Attitude Inventory (DAI), Beck Depression Inventory (BDI), Perceived Stress Scale (PSS), and Clinical Global Impression (CGI) were administered prior to and after CBT sessions. The participants were categorized into two groups according to the median duration of untreated psychosis (DUP; 4 months).
Results: A total of 34 patients were included in this analysis. From pre- to post-therapy, there were significant increases in the SWN-K and DAI scores and significant decreases in the hostility subscale of the AIHQ, PSS, and CGI scores. Significant time × DUP interaction effects were observed for the SWN-K, DAI, and BDI scores, such that there were significant changes in patients with a short DUP but not in those with a long DUP.
Conclusion: The group CBT program had a positive effect on subjective wellbeing, attitude toward treatment, perceived stress, and suspiciousness of young Korean patients with early psychosis. These effects were particularly significant in patients with a short DUP.

참고문헌 (Reference)

1 이종하, "한글판 스트레스 자각척도의 신뢰도와 타당도 연구" 한국정신신체의학회 20 (20): 127-134, 2012

2 윤보현, "한국판 약물태도 척도의 심리측정적 특성" 대한정신약물학회 16 (16): 480-487, 2005

3 장형윤, "한국어판 모호한 의도-적개심 설문지 개발" 대한신경정신의학회 48 (48): 29-35, 2009

4 이가영, "젊은 조현병 환자의 사회복귀를 위한 인지행동치료 기반 집중사례관리 증례" 대한조현병학회 19 (19): 32-37, 2016

5 김성완, "단축형 항정신병약물치료 중 주관적 안녕감 척도의 표준화 연구" 대한정신약물학회 18 (18): 221-230, 2007

6 Harris MG, "The relationship between duration of untreated psychosis and outcome : an eight-year prospective study" 79 : 85-93, 2005

7 McGorry PD, "The recognition and optimal management of early psychosis : an evidence-based reform" 1 : 76-83, 2002

8 Kim SW, "The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia" 38 : 228-235, 2012

9 Zimmermann G, "The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders : a meta-analysis" 77 : 1-9, 2005

10 Cohen S, "The Social Psychology of Health" Sage Publications, Inc 31-67, 1988

11 Combs DR, "The Ambiguous Intentions Hostility Questionnaire(AIHQ) : a new measure for evaluating hostile social-cognitive biases in paranoia" 12 : 128-143, 2007

12 Malla AK, "Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis" 32 : 1109-1119, 2002

13 Moritz S, "Sustained and"sleeper"effects of group metacognitive training for schizophrenia : a randomized clinical trial" 71 : 1103-1111, 2014

14 Cohen J., "Statistical Power Analysis for the Behavioral Sciences" Lawrence Earlbaum Associates 1988

15 Hahn HM, "Standardization study of Beck Depression Inventory in Korea" 25 : 487-502, 1986

16 Lambert M, "Remission of severely impaired subjective well-being in 727 patients with schizophrenia treated with amisulpride" 115 : 106-113, 2007

17 Perkins DO, "Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia : a critical review and meta-analysis" 162 : 1785-1804, 2005

18 유태영, "Relationship between Suicidality and Low Self-esteem in Patients with Schizophrenia" 대한정신약물학회 13 (13): 296-301, 2015

19 Jones PB, "Randomized controlled trial of the effect on quality of life of second-versus first-generation antipsychotic drugs in schizophrenia : Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study(CUtLASS 1)" 63 : 1079-1087, 2006

20 Wehmeier PM, "Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia" 30 : 703-712, 2007

21 Mueser KT, "Psychosocial treatments for schizophrenia" 9 : 465-497, 2013

22 National Institute for Health and Care Excellence, "Psychosis and schizophrenia in adults: prevention and management (Clinical guideline 178)"

23 Tang JY, "Prospective relationship between duration of untreated psychosis and 13-year clinical outcome : a first-episode psychosis study" 153 : 1-8, 2014

24 Naeem F, "Predictors of response to cognitive behavior therapy in the treatment of schizophrenia : a comparison of brief and standard interventions" 32 : 651-656, 2008

25 Brabban A, "Predictors of outcome in brief cognitive behavior therapy for schizophrenia" 35 : 859-864, 2009

26 Perkins D, "Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders" 185 : 18-24, 2004

27 Alvarez-Jiménez M, "Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis" 54 : 710-718, 2009

28 Alvarez-Jimenez M, "Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis" 125 : 236-246, 2011

29 Combs DR, "Perceptions of hostility with and without persecutory delusions" 14 : 30-52, 2009

30 Karow A, "PANSS syndromes and quality of life in schizophrenia" 38 : 320-326, 2005

31 Compton MT, "Mode of onset of psychosis and family involvement in help-seeking as determinants of duration of untreated psychosis" 43 : 975-982, 2008

32 Ussorio D, "Metacognitive training for young subjects (MCT young version) in the early stages of psychosis: is the duration of untreated psychosis a limiting factor?" 89 : 50-65, 2016

33 Garety P, "London-East Anglia randomised controlled trial of cognitive-behaviour therapy for psychosis. II: Predictors of outcome" 171 : 420-426, 1997

34 Rangaswamy T, "Intervention for first episode psychosis in India-The SCARF experience" 5 : 58-62, 2012

35 Vitzthum FB, "Individualized metacognitive therapy program for patients with psychosis(MCT+) : introduction of a novel approach for psychotic symptoms" 42 : 105-110, 2014

36 Menon M, "Individual factors predicted to influence outcome in group CBT for psychosis(CBTp)and related therapies" 6 : 1563-, 2015

37 Naber D, "Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs" 50 : 79-88, 2001

38 Chang WC, "Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia : a 3-year prospective follow-up study" 43 : 1883-1893, 2013

39 Marshall M, "Impact of early intervention services on duration of untreated psychosis : data from the National EDEN prospective cohort study" 159 : 1-6, 2014

40 Schimmelmann BG, "Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort" 42 : 982-990, 2008

41 Chung YC, "Group cognitive-behavioral therapy for early psychosis" 37 : 403-411, 2013

42 Lecomte T, "Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial" 196 : 866-875, 2008

43 Lecomte T, "Group CBT for early psychosis--are there still benefits one year later?" 62 : 309-321, 2012

44 McGorry PD, "Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages" 187 (187): S8-S10, 2007

45 McGorry PD, "Early intervention in psychosis: concepts, evidence and future directions" 7 : 148-156, 2008

46 Birchwood M, "Early intervention in psychosis. The critical period hypothesis" 172 : 53-59, 1998

47 Bertolote J, "Early intervention and recovery for young people with early psychosis: consensus statement" 48 : S116-S119, 2005

48 Karow A, "EGOFORS Initiative. Remission as perceived by people with schizophrenia, family members and psychiatrists" 27 : 426-431, 2012

49 Guy W, "ECDEU Assessment Manual for Psychopharmacology"

50 Uçok A, "Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia" 38 : 163-168, 2004

51 Penttilä M, "Duration of untreated psychosis as predictor of long-term outcome in schizophrenia : systematic review and meta-analysis" 205 : 88-94, 2014

52 Lappin JM, "Duration of untreated psychosis and neuropsychological function in first episode psychosis" 95 : 103-110, 2007

53 Norman RM, "Duration of untreated psychosis and its relationship to clinical outcome" 48 : S19-S23, 2005

54 Addington J, "Duration of Untreated Psychosis in Community Treatment Settings in the United States" 66 : 753-756, 2015

55 Beauchamp MC, "Do personality traits matter when choosing a group therapy for early psychosis?" 86 : 19-32, 2013

56 American Psychiatric Association, "Diagnostic and statistical manual of mental disorders"

57 Kim SW, "Development and feasibility of smartphone application for cognitive behavioral case management of individuals with early psychosis" 2016

58 Moritz S, "Detecting and defusing cognitive traps : metacognitive intervention in schizophrenia" 23 : 561-569, 2010

59 Kane JM, "Comprehensive versus usual community care for first-episode psychosis : 2-year outcomes from the NIMH RAISE early treatment program" 173 : 362-372, 2016

60 Moritz S, "Complementary group Metacognitive Training(MCT)reduces delusional ideation in schizophrenia" 151 : 61-69, 2013

61 Tarrier N, "Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial" 184 : 231-239, 2004

62 Moritz S, "Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics" 33 : 48-51, 2000

63 Wykes T, "Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor" 34 : 523-537, 2008

64 Beck AT, "Cognitive approaches to schizophrenia : theory and therapy" 1 : 577-606, 2005

65 An SK, "Attribution bias in ultra-high risk for psychosis and first-episode schizophrenia" 118 : 54-61, 2010

66 Marshall M, "Association between duration of untreated psychosis and outcome in cohorts of first-episode patients : a systematic review" 62 : 975-983, 2005

67 Rossi A, "Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone" 23 : 216-222, 2008

68 Tarrier N, "Are all psychological treatments for psychosis equal? The need for CBT in the treatment of psychosis and not for psychodynamic psychotherapy" 75 : 365-374, 2002

69 Beck AT, "An inventory for measuring depression" 4 : 561-571, 1961

70 Hogan TP, "A self-report scale predictive of drug compliance in schizophrenics : reliability and discriminative validity" 13 : 177-183, 1983

71 Naber D., "A self-rating to measure subjective effects of neuroleptic drug relationships to objective psychopathology, quality of life, compliance, and other clinical variables" 10 (10): 133-138, 1995